Trial Profile
A Phase II Study to Assess the Safety and Immunogenicity of subcutaneous DNK-FLU in Healthy Japanese Adults
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Feb 2017
Price :
$35
*
At a glance
- Drugs Influenza virus vaccines (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Acronyms DNK-ADUFLU-3
- Sponsors Denka Seiken
- 07 Jun 2016 New trial record